Proteomic Mendelian randomization to identify protein biomarkers of telomere length
- PMID: 39284832
- PMCID: PMC11405721
- DOI: 10.1038/s41598-024-72281-7
Proteomic Mendelian randomization to identify protein biomarkers of telomere length
Abstract
Shortening of telomere length (TL) is correlated with many age-related disorders and is a hallmark of biological aging. This study used proteome-wide Mendelian randomization to identify the protein biomarkers associated with telomere length. Protein quantitative trait loci (pQTL) were derived from two studies, the deCODE Health study (4907 plasma proteins) and the UK Biobank Pharma Proteomics Project (2923 plasma proteins). Summary data from genome-wide association studies (GWAS) for TL were obtained from the UK Biobank (472,174 cases) and GWAS Catalog (418,401 cases). The association between proteins and TL was further assessed using colocalization and summary data-based Mendelian randomization (SMR) analyses. The protein-protein network, druggability assessment, and phenome-wide MR were used to further evaluate the potential biological effects, druggability, and safety of the target proteins. Proteome-wide MR analysis identified 22 plasma proteins that were causally associated with telomere length. Five of these proteins (APOE, SPRED2, MAX, RALY, and PSMB1) had the highest evidence of association with TL and should be prioritized. This study revealed telomere length-related protein biomarkers, providing new insights into the development of new treatment targets for chronic diseases and anti-aging intervention strategies.
Keywords: Mendelian randomization; Protein; Telomere length.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Genetic analysis from multiple cohorts implies causality between 2200 druggable genes, telomere length, and leukemia.Comput Biol Med. 2024 Oct;181:109064. doi: 10.1016/j.compbiomed.2024.109064. Epub 2024 Aug 30. Comput Biol Med. 2024. PMID: 39216403
-
PTGES2 and RNASET2 identified as novel potential biomarkers and therapeutic targets for basal cell carcinoma: insights from proteome-wide mendelian randomization, colocalization, and MR-PheWAS analyses.Front Pharmacol. 2024 Jul 5;15:1418560. doi: 10.3389/fphar.2024.1418560. eCollection 2024. Front Pharmacol. 2024. PMID: 39035989 Free PMC article.
-
Identifying new biomarkers and potential therapeutic targets for breast cancer through the integration of human plasma proteomics: a Mendelian randomization study and colocalization analysis.Front Endocrinol (Lausanne). 2024 Sep 16;15:1449668. doi: 10.3389/fendo.2024.1449668. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39351539 Free PMC article.
-
New insights from bidirectional Mendelian randomization: causal relationships between telomere length and mitochondrial DNA copy number in aging biomarkers.Aging (Albany NY). 2024 Apr 24;16(8):7387-7404. doi: 10.18632/aging.205765. Epub 2024 Apr 24. Aging (Albany NY). 2024. PMID: 38663933 Free PMC article.
-
Plasma proteins and psoriatic arthritis: a proteome-wide Mendelian randomization study.Front Immunol. 2024 Jul 4;15:1417564. doi: 10.3389/fimmu.2024.1417564. eCollection 2024. Front Immunol. 2024. PMID: 39026678 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous